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Loss of porin function in dopaminergic
neurons of Drosophila is suppressed
by Buffy
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Abstract
Background: Mitochondrial porin, also known as the voltage-dependent anion channel (VDAC), is a multi-functional
channel protein that shuttles metabolites between the mitochondria and the cytosol and implicated in cellular life and
death decisions. The inhibition of porin under the control of neuronal Ddc-Gal4 result in short lifespan and in an
age-dependent loss in locomotor function, phenotypes that are strongly associated with Drosophila models of
Parkinson disease.
Methods: Loss of porin function was achieved through exploitation of RNA interference while derivative lines
were generated by homologous recombination and tested by PCR. The UAS/Gal4 expression system was exploited
with directed expression in neurons achieved with the use of the Dopa decarboxylase and in the developing eye with
the Glass multiple reporter transgenes. Statistical analyses for ageing assay employed Log rank (Mantel-Cox) test,
climbing indices were fitted with a non-linear curve and confidence intervals compared at 95%. Biometric analysis of
the eye phenotypes was obtained by unpaired student T-test.
Results: The expression of α-synuclein in neuronal populations that include dopamine producing neurons under the
control of Ddc-Gal4 produces a robust Parkinson disease model, and results in severely reduced lifespan and locomotor
dysfunction. In addition, the porin-induced phenotypes are greatly suppressed when the pro-survival Bcl-2 homologue
Buffy is overexpressed in these neurons and in the developing eye adding to the cellular advantages of altered
expression of this anti-apoptotic gene. When we co-expressed α-synuclein along with porin, it results in a decrease in
lifespan and impaired climbing ability. This enhancement of the α-synuclein-induced phenotypes observed in neurons
was demonstrated in the neuron rich eye, where the simultaneous co-expression of porin-RNAi and α-synuclein resulted
in an enhanced eye phenotype, marked by reduced number of ommatidia and increased disarray of the ommatidia.
Conclusions: The inhibition of porin in dopaminergic neurons among others result in reduced lifespan and age-
dependent loss in climbing ability, phenotypes that are suppressed by the overexpression of the sole pro-survival Bcl-2
homologue Buffy. The inhibition of porin phenocopies Parkinson disease phenotypes in Drosophila, while the
overexpression of Buffy can counteract these phenotypes to improve the overall “healthspan” of the organism.
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Background
The voltage-dependent anion channel (VDAC), also
known as mitochondrial porin, consists of small pore-
forming proteins present in the outer mitochondrial
membrane that act to shuttle nucleotides, metabolites
and ions between the mitochondria and the cytoplasm
[1, 2]. Porin is a multi-functional protein and is in-
volved in the regulation of metabolism and energetic
functions of the mitochondria and a constituent of the
mitochondrial permeability transition pore (PTP) [3].
Porin is involved in apoptosis, metabolite transport, cal-
cium transport and signalling, ATP transport, reactive
oxygen species transport and endoplasmic reticulum –
mitochondrial crosstalk [3–5]. As thus porin appears to be
a convergence point for cell death and survival signals,
mediated by its association with a variety of ligands and
proteins. Porin is implicated in mitochondria-mediated
apoptosis and in regulation of apoptosis through inter-
action with pro-survival proteins [3]. It interacts with the
pro-survival hexokinase to mediate its anti-apoptotic ac-
tivity [3, 6], and the Bcl-2 family of proteins to regulate
mitochondria-mediated apoptosis [7, 8]. This association
can induce cell survival or death.
The porin gene is associated with several neurodegener-
ative disorders including Alzheimer disease [9], Down syn-
drome [10], and dopamine-induced apoptosis [11]. The
association of porin with Parkinson disease-associated
gene products has been established, where it recruits par-
kin to defective mitochondria to promote mitophagy [12],
and shows high affinity interaction with α-synuclein to
regulate mitochondrial-induced toxicity [13]. This study
suggests that α-synuclein translocate to the mitochondria
via porin to target complexes of the mitochondrial respira-
tory chain. The accumulation and aggregation of abnormal
α-synuclein was shown to down-regulate porin [14] and
possibly regulate mitochondrial permeability [15]. The
association between the PD gene α-synuclein and the
mitochondrial channel porin appears to be important in
the progression of PD. The initial Drosophila PD model
employed the expression of human α-synuclein transgene
to generate the PD-like phenotypes [16], that are com-
monly known as the α-synuclein-induced phenotypes. The
success of this model anchors on its ability to phenocopy
features of human PD such as the age-dependent loss in
locomotor function and therefore, has found application
in the study of α-synuclein-induced degeneration [16–23].
The use of the bipartite UAS/GAL4 expression system
[24], and the remarkable number of promoters or en-
hancers available, of which TH-Gal4, elav-Gal4 and
Ddc-Gal4 are utilized in modelling PD in flies [16–23],
makes Drosophila a useful and albeit a powerful model
organism.
The loss of function of Drosophila porin/VDAC has
been shown to result in mitochondrial morphological
defects [25, 26]. These mitochondrial defects were ac-
companied by locomotor dysfunction and male sterility.
In addition, porin mutants displayed neurological and
muscular defects, mitochondrial respiratory defects, and
abnormalities in synaptic transmission and mitochon-
drial distribution in motor neurons. Here we suppressed
porin by RNA interference in Drosophila neurons under
the control of the dopa decarboxylase transgene and
analysed longevity and locomotor ability. Further we
co-expressed porin-RNAi with α-synuclein to investi-
gate its effects in the well-studied Drosophila PD
model. The association of porin with Bcl-2 members is
well documented, we have demonstrated the benefits of
overexpression of the sole anti-apoptotic Bcl-2 member
Buffy in conditions of stress [27, 28], as thus, we over-
expressed Buffy along with porin-RNAi. In addition, we
altered the expression of porin in the Drosophila devel-
oping eye and co-expressed with α-synuclein and Buffy.
Methods
Bioinformatic analysis
The protein sequences were sourced from National
Center for Biotechnology Information (NCBI; http://
www.ncbi.nlm.nih.gov/protein/) while conserved do-
mains were identified using the NCBI Conserved Domain
Database (CDD; http://www.ncbi.nlm.nih.gov/cdd) [29]
and the Eukaryotic Linear Motif [30] (http://elm.eu.org/)
which focuses on annotation and detection of eukaryotic
linear motifs (ELMs) or short linear motifs (SLiMs).
Clustal Omega multiple sequence alignment (http://
www.ebi.ac.uk/Tools/msa/clustalo/) [31, 32] was used
to show conservation of the porin3_VDAC domain in the
selected organisms. The nuclear export signal (NES) was
predicted by NetNES (http://www.cbs.dtu.dk/services/
NetNES/) [33] and TMpred, a program that predicts
membrane-spanning regions and their orientation. The al-
gorithm is based on the statistical analysis of TMbase, a
database of naturally occurring transmembrane proteins
(http://www.ch.embnet.org/software/TMPRED_form.html).
Drosophila media and culture
Stocks and crosses were maintained on standard corn-
meal/molasses/yeast/agar media treated with propionic
acid and methylparaben to inhibit fungal growth. Stocks
were maintained on solid media for 2 to 3 weeks before
transfer onto new media to re-culture. Stocks were kept
at room temperature (22 °C ± 2 °C) while crosses and ex-
periments were carried out at 25 and 29 °C.
Drosophila stocks
The P{KK107645}VIE-260B hereby referred to as UAS-porin-
RNAi (1) was obtained from Vienna Drosophila Resource
Center, y[1] v[1]; P{y[+t7.7] v[+t1.8] =TRiP.JF03251}attP2/
TM3, Sb[1] hereby known as UAS-porin-RNAi (2). Porin
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expression patterns are detailed in FlyBase http://flybase.org/
reports/FBgn0004363.html, and in the Berkeley Drosophila
Genome Project (BDGP; http://flybase.org/reports/
FBgn0004363.html) [34]. Similarly, a thorough expres-
sion study was performed by Olivia et al., 2002 and
showed a wide range of patterns [35]. GMR-Gal4 [36]
and UAS-lacZ flies were obtained from the Blooming-
ton Drosophila Stock Center at Indiana University.
UAS-α-synuclein [16] was generously provided by Dr.
M. Feany of Harvard Medical School, Ddc-Gal4 [37] by
Dr. J. Hirsch of University of Virginia and UAS-Buffy
[38] by Dr. L. Quinn of University of Melbourne. Stud-
ies to establish the expression pattern of Buffy have
previously been performed [38, 39]. They detected
Buffy mRNA via RT-PCR at all developmental stages,
with the strongest expression being at the late larval/ early
pupal stage [38]. The expression patterns correlate with re-
gions of cell death and occurs in the same pattern as the pro-
cell death Debcl [38, 40]. Additional expression data is found
onFlyBase http://flybase.org/reports/FBgn0040491.html.
Drosophila derivative lines
The UAS-α-synuclein/CyO; Ddc-Gal4/TM3, UAS-α-
synuclein/CyO; GMR-Gal4, UAS-Buffy/CyO; Ddc-Gal4
and UAS-Buffy/CyO; GMR-Gal4 derivative lines were
generated using standard homologous recombination
methods that we have previously described [41, 42] and
were used for the overexpression of either α-synuclein
or Buffy in DA and other neurons using the Ddc-Gal4
transgene or in the developing eye using the GMR-Gal4
transgene. PCR reaction was used to determine the
amplification of DNA products and Gel electrophoresis
was used for confirmation of recombination events via
presence of the PCR product.
Ageing assay
The analysis for survival was performed following a
protocol that has previously been described [27, 43]. But
briefly, from each genotype crosses were made and a co-
hort of at least two hundred flies collected and aged.
Flies were considered dead when they did not display
movement upon agitation [44]. Survival curves were
compared using the log-rank (Mantel-Cox) test and sig-
nificance was determined at 95%, at a P-value less than
or equal to 0.05 with Bonferroni correction.
Climbing assay
Analysis for climbing ability was determined using a
standard protocol that was described in our laboratory
[45]. This assay scores the flies ability to climb over their
lifetime and analyses 50 males from every genotype.
Climbing indices obtained were analysed using Graph-
Pad Prism version 5.04 and climbing curves were fitted
using non-linear regression. Comparisons were done at
a 95% confidence interval with a P-value threshold of
less than 0.05 considered significant.
Scanning electron microscopy of the Drosophila eye
The Drosophila eyes for scanning electron microscopy
and analysis were prepared following a standard proto-
col, as previously described [27]. At least 10 different eye
images per genotype were analysed using the National
Institutes of Health (NIH) ImageJ software [46]. The
proportion of the disrupted eye area was calculated as
detailed in a previous publication [47]. Statistical com-
parisons were evaluated using a one-way analysis of vari-
ance followed by a Dunnett’s multiple comparison tests.
P-values less than 0.05 were considered significant.
Results
The human and Drosophila porin domain is conserved
There is 62% identity and 77% similarity between the
human porin (VDAC) and the Drosophila melanogaster
porin protein sequences, with very high conservation
within the Porin3_VDAC domain (Fig. 1). The putative
dimerization interface and putative determinants of
voltage-gated binding sites are well conserved as deter-
mined by an NCBI conserved domain search [29]. A
Eukaryotic linear motif (ELM) resource search for func-
tional sites [48] in the Drosophila transcript indicates
the presence of an inhibitor of apoptosis binding motif
(IBM) that function in the abrogation of caspase inhib-
ition by inhibitors of apoptosis (IAPs) at amino acids 1
to 5, an Atg8 binding motif at amino acids 5 to 9, a nu-
clear export signal (NES) at amino acids 91 to 98, a PDZ
domain at amino acids 277 to 282 and a transmembrane
domain predicted by TMpred.
Inhibition of porin in neurons decreases lifespan and
severely impairs locomotor function, phenotypes that are
suppressed by Buffy overexpression
The expression of porin-RNAi in Ddc-Gal4-expressing
neurons results in a slightly decreased lifespan and se-
verely impaired locomotor function as shown by the two
RNAi lines that we tested. The median lifespan for these
flies was 48 and 52 days when compared to 68 days for
the controls as determined by Log-rank (Mantel-Cox)
test with a p < 0.0001 (Fig. 2a). When porin is suppressed
in these neurons, the flies have impaired locomotor abil-
ity as determined by comparison of CI after the nonlin-
ear fit of the climbing curves (Fig. 2b). These results
suggest a role for porin in the normal function of neu-
rons in Drosophila since its reduced activity shortens
lifespan and prematurely retards climbing ability.
The directed overexpression of the pro-survival Bcl-2
homologue Buffy in these neurons resulted in increased
lifespan and improved climbing ability. When Buffy is
co-expressed with the porin-RNAi lines, the results
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indicate a median lifespan of 70 and 69 days when com-
pared to 72 days for Buffy co-expression with lacZ con-
trol flies as determined by Log-rank test (Fig. 2c). The
climbing ability of the porin-RNAi flies was significantly
improved as determined by comparison of climbing
curves of porin-RNAi flies at 95% CI (Fig. 2b) with the
flies that express porin-RNAi along with Buffy and with
the control flies that co-expressed Buffy along with lacZ
(Fig. 2d). Taken together these results suggest a pro-
survival role for Buffy as observed by significant in-
creases in the “healthspan” of porin-deficient flies.
Inhibition of porin enhances α-synuclein-dependent
phenotypes
The expression of α-synuclein in Ddc-Gal4-expressing
neurons results in impaired locomotor function that has
been attributed to cellular toxicity due to the accumula-
tion of this protein. The co-expression of the porin-
RNAi lines along with α-synuclein, decreased survival
and impaired climbing ability over time (Fig. 3). The me-
dian lifespan was 50 and 56 days for flies that expressed
porin-RNAi along with α-synuclein, compared to 60 days
for control flies that co-expressed α-synuclein along with
lacZ, a significant decrease in survival for both RNAi
lines (Fig. 3a) as determined by Log-rank (Mantel-Cox)
test (p < 0.0001). A comparison of the climbing curves
by nonlinear fitting at 95% CI revealed they were signifi-
cantly different (Fig. 3b), with CI of 0.04691 to 0.06795
and 0.030 to 0.050 for flies that expressed porin-RNAi
along with α-synuclein, compared to 0.06842 to 0.08366
for control flies that co-expressed α-synuclein along with
lacZ. This suggests that the inhibition of porin together
with the expression of α-synuclein in these neurons con-
fers a significant health disadvantage, with marked de-
creases in survival and premature loss of climbing
ability.
Inhibition of porin in the eye decreases ommatidia
number and increases ommatidial disarray, phenotypes
that are rescued by Buffy overexpression
When porin-RNAi is directed in the developing eye
using the GMR-Gal4 transgene, it results in eyes with
decreased number of ommatidia and higher disruption
of the ommatidial array (Fig. 4ii, iii and x) as determined
Fig. 1 Drosophila porin has a conserved Porin3_VDAC domain. The Drosophila melanogaster porin gene encodes a 282 amino acids protein and
the Porin domain is highly conserved when compared to the human homologue. It shows presence of a nuclear export signal (NES), a transmembrane
domain, and a PDZ domain. Domains were identified using the NCBI Conserved Domain Database Search (CDD) [29] and the Eukaryotic Linear Motif
resource search [30]. A Clustal Omega multiple sequence alignment [31, 32] show conservation of the porin3_VDAC domain (Hsap is Homo sapiens
NP_003366.2, Dmel is Drosophila melanogaster NP_001033899.1 and Agam is Anopheles gambiae XP_318947.2). “*” indicate the residues that
are identical, “:” indicate the conserved substitutions, “.” indicate the semi-conserved substitutions. Colours show the chemical nature of amino
acids. Red is small hydrophobic (including aromatic), Blue is acidic, Magenta is basic, and Green is basic with hydroxyl or amine groups
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by a one-way analysis of variance followed by a Dunnett’s
multiple comparison test p < 0.0001. Co-expression of
porin with Buffy restored the mean number of ommatidia
and the percentage disruption to control levels as deter-
mined by a one-way analysis of variance followed by a
Dunnett’s multiple comparison test p > 0.05 (Fig. 4v, vi
and xi). Taken together, these results suggest that porin
may play a role in the development of the Drosophila eye
and that Buffy suppresses the developmental eye defects
that result from the inhibition of porin. The inhibition of
porin along with α-synuclein overexpression resulted in a
significant decrease in the number of ommatidia due to
fusion of ommatidia and an increase in the percentage dis-
ruption of the eye (Fig. 4 viii, ix and xii) as determined by
a one-way analysis of variance followed by a Dunnett’s
multiple comparison test p < 0.0001. This suggests an
enhancement of the neurotoxic effects of the α-synu-
clein-induced developmental eye defects in the pres-
ence of reduced porin activity.
Discussion
The multitude of functions attributed to mitochondrial
porin or VDAC and its control of the entry and exit of
mitochondrial metabolites makes it a key player in the
cellular decisions that lead to either survival or death
[1]. The expression of porin-RNAi in neurons under the
direction of the Ddc-Gal4 transgene results in shortened
lifespan and a premature loss in locomotor ability, re-
sults that were consistent in both RNAi lines tested and
that corroborate previous studies [25, 26]. This gene
product is involved in maintaining mitochondrial
morphology, and its disruption leads to a host of pheno-
types among them locomotor defects. In our study, we
disrupted this protein in DA and other neurons, the re-
sults obtained signifies a close connection between
porin and the progression of the PD-like phenotypes of
shortened lifespan and an age-dependent loss in loco-
motor function. The comparison of climbing indices of
flies at 40 days when most of them are alive to the con-
trol lines indicate a significant change in the pheno-
types, these appears to be a strong indication of
possible neurodegeneration.
The relationship between mitochondrial porin and PD
susceptibility gene products has been investigated in
other organisms [12–14, 49, 50]. The inhibition of porin
along with the expression of α-synuclein in Ddc-Gal4-
expressing neurons of Drosophila melanogaster results
in the enhancement of the loss of α-synuclein-induced
phenotypes, with a decrease in lifespan and an impair-
ment in climbing ability. Some studies have attributed
the neurotoxicity of α-synuclein to its interaction with
electron transport chain components among them Com-
plex I [51]. It has been suggested that α-synuclein blocks
the activity of porin and uses this channel to translocate
Fig. 2 Loss of porin activity decreases survival and impairs climbing ability. a The inhibition of porin in neurons using the Ddc-Gal4 transgene
results in decreased median lifespan of 48 and 52 days when compared to 68 days for control flies that expresses UAS-lacZ. The genotypes are
Ddc-Gal4/ UAS-lacZ, Ddc-Gal4/ UAS-porin-RNAi (1) and Ddc-Gal4/ UAS-porin-RNAi (2). Longevity is shown as percent survival (P < 0.05, determined
by the log-rank (Mantel-Cox) test and n ≥ 200). b The inhibition of porin in the Ddc-Gal4-expressing neurons resulted in a significant decrease in
climbing ability as determined by nonlinear fitting of the climbing curves and comparing 95% CI. The genotypes are Ddc-Gal4/ UAS-lacZ, Ddc-Gal4/
UAS-porin-RNAi (1) and Ddc-Gal4/ UAS-porin-RNAi (2). Error bars indicate SEM and n = 50. c The co-expression of Buffy with porin-RNAi result in the rescue
of the observed phenotype of decreased survival, with a median survival of 70 and 69 days when compared to 72 days for controls. Genotypes are
Ddc-Gal4 UAS-Buffy/ UAS-lacZ, Ddc-Gal4 UAS-Buffy/ UAS-porin-RNAi (1) and Ddc-Gal4 UAS-Buffy/ UAS-porin-RNAi (2). Longevity is shown as percent survival
(P < 0.05, determined by log-rank (Mantel-Cox) test with n ≤ 200). d The inhibition of porin along with the overexpression of Buffy in the DA
neurons results in the suppression of the age-dependent loss in climbing ability. The genotypes are Ddc-Gal4 UAS-Buffy/ UAS-lacZ, Ddc-Gal4
UAS-Buffy/ UAS-porin-RNAi (1) and Ddc-Gal4 UAS-Buffy/ UAS-porin-RNAi (2). Analysis was done by nonlinear fitting of the climbing curves and
significance was determined by comparing the 95% CI. Error bars indicate SEM and n = 50
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into the inner mitochondria [13] and that it preferen-
tially interacts with mitochondrial membranes compared
to other organelle membranes [52]. This association in-
hibits mitochondrial function and promotes reactive
oxygen stress. Our study firstly inhibited the mitochon-
dria porin and secondly expressed α-synuclein in the
same neurons, this resulted in the enhancement of the
observed phenotypes, with shortened lifespan and severe
reduction in climbing ability over time. It seems there-
fore that the combination effect of the directed inhib-
ition of porin, and expression of α-synuclein confers a
greater disadvantage to “healthspan”, albeit when altered
in neurons. When altered individually, α-synuclein-in-
duced PD model, a well-studied and robust disease
model in Drosophila [16, 22] result in shortened lifespan
and impaired climbing ability. Inhibition of porin in the
developing eye results in extensive ommatidial disrup-
tion and fewer ommatidia number, because of intensive
fusion of the ommatidia with no distinct ommatidia de-
tectable in most of the eyes analysed. We suggest that
though α-synuclein interacts with the mitochondria to
result in disruption of mitochondria homeostasis, loss of
porin in neurons seem to be independent of α-synuclein-
induced phenotypes and this highlights the complexity
of mechanisms involved in the pathogenesis of PD.
The association of porin with members of the Bcl-2
family is well documented [7], and has been suggested
to be a point of convergence for cell survival and death
Fig. 3 Loss of porin function enhances the α-synuclein-induced reduction in lifespan and age-dependent loss of climbing ability. a The directed
inhibition of porin along with α-synuclein expression in the neurons decreased lifespan with a median survival of 50 and 56 days when compared
to 60 days for the control flies that express α-synuclein along with the lacZ transgene. Genotypes are UAS-α-synuclein; Ddc-Gal4/ UAS-lacZ,
UAS-α-synuclein; Ddc-Gal4/UAS-porin-RNAi (1) and UAS-α-synuclein; Ddc-Gal4/ UAS-porin-RNAi (2). Longevity is shown as percent survival
(P < 0.05, determined by log-rank (Mantel-Cox) test with n ≤ 200). b The co-expression of porin-RNAi with α-synuclein resulted in reduction
of climbing ability over time when compared to the controls. The genotypes are UAS-α-synuclein; Ddc-Gal4/UAS-lacZ, UAS-α-synuclein;
Ddc-Gal4/UAS-porin-RNAi (1) and UAS-α-synuclein; Ddc-Gal4/UAS-porin-RNAi (2). Analysis was done by nonlinear fitting of the climbing curves
and significance was determined by comparing the 95% CI. Error bars indicate SEM and n = 50
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Fig. 4 (See legend on next page.)
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signals [3]. When we overexpressed Buffy, the sole pro-
survival Bcl-2 homologue, in Drosophila neurons, along
with inhibition of porin via RNAi, the phenotypes associ-
ated with the loss-of-function of porin, shortened life-
span and impaired climbing ability, were suppressed.
The survival-induced advantages of Buffy especially
under conditions of stress are well documented [27, 28,
38, 41, 42], and so is the regulation of porin by Bcl-2
proteins that underscores the importance of Bcl-2 pro-
tein in life and death decisions. The overexpression of
Buffy along with the inhibition of porin in Ddc-Gal4-ex-
pressing neurons and in the developing eye resulted in a
suppression of the phenotypes. The excess Buffy product
must therefore confer cellular advantages to the target
cells and counteracts the toxic effects of porin inhibition,
and demonstrates a wider role for the Drosophila pro-
survival homologue, with potential involvement in the
mitochondria-mediated cell death. The developmental
expression patterns of Buffy and porin can shed light on
the resulting phenotypes and possibly on the counter-
action of the porin-induced phenotypes by overexpres-
sion of Buffy. One study has suggested that porin was
not involved in debcl-induced cell death [25] and found
that apoptosis induced by debcl overexpression was not
inhibited by porin loss of function. As such it seems that
the rescue of porin-induced phenotypes by Buffy are
consistent with its action on the mitochondria directly
or through other proteins in a dedicated pro-survival
signalling pathway.
Conclusions
The inhibition of porin in the Ddc-Gal4-expressing neu-
rons and the developing eye is rescued upon the over-
expression of Buffy, a pro-survival Bcl-2 homologue.
The co-expression of porin-RNAi along with α-synu-
clein results in enhanced phenotypes, this highlights
the complexity of α-synuclein-induced mechanisms
in the pathogenesis of PD, and in deed demonstrates
the multi-faceted mechanisms involved in the aeti-
ology of PD.
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